Home › Cases › Incidental PE on CT Scan
Pulmonary Embolism
Incidental PE on CT Scan
6 questions
Question 1 · Incidental PE
Correct answer: Anticoagulation is generally recommended even for incidental PE, but evidence less clear for isolated sub-segmental
Why
Incidental PE: anticoagulation generally recommended, especially in cancer patients (high recurrence risk). Isolated sub-segmental PE: some controversy — consider anticoagulation vs watchful waiting based on symptoms, cancer type, bleeding risk. All symptomatic PE: anticoagulate.
Key point
Incidental PE: anticoagulate in most cases, especially in cancer. Sub-segmental PE: discuss risk/benefit.
Question 2 · Anticoagulation in cancer-associated PE
Correct answer: A DOAC such as apixaban/rivaroxaban, or LMWH if unsuitable—check bleeding risk and interactions
Why
Cancer-associated VTE: consider a DOAC; LMWH such as dalteparin is appropriate if unsuitable. Check tumour site, GI/GU bleeding risk, absorption and anticancer-drug interactions. Cancer trials include SELECT-D, Hokusai VTE Cancer and Caravaggio; CACTUS concerned calf DVT without active cancer.
Key point
Cancer PE: DOAC or LMWH, chosen for tumour site, bleeding risk and interactions.
Question 3 · Duration of anticoagulation
Correct answer: Minimum 6 months. Continue indefinitely while cancer active and PE risk outweighs bleeding risk
Why
Cancer-associated PE: minimum 6 months. Continue anticoagulation while cancer is active or being treated (high ongoing VTE risk). Reassess every 3-6 months. If cancer in remission/treated: duration becomes less clear — ongoing risk assessment.
Key point
Cancer PE: minimum 6 months. Continue while cancer active. Reassess every 3-6 months.
Question 4 · Risk stratification
Correct answer: Haemodynamic stability, RV dysfunction (echo/CT), troponin, BNP — PESI score
Why
PE severity: haemodynamic status primary. Intermediate-high risk requires an elevated clinical score plus both RV dysfunction and positive troponin. Elevated troponin and BNP indicate myocardial stress. PESI score (clinical score) guides outpatient vs inpatient management. Asymptomatic does not equal low risk.
Key point
PE severity: haemodynamics, RV dysfunction, troponin, BNP, PESI. Asymptomatic PE can still have RV strain.
Question 5 · Outpatient PE management
Correct answer: Low-risk PE can be managed outpatient with early discharge or direct-to-outpatient protocols
Why
Low-risk PE (PESI I-II, no RV dysfunction, no troponin elevation, adequate home support): outpatient management is safe and recommended. RIETE nomogram and Hestia criteria guide suitability. Outpatient management reduces costs and hospital-acquired harm.
Key point
Low-risk PE may be managed outpatient after bleeding, comorbidity, home-support and follow-up checks.
Question 6 · VTE prevention in cancer
Correct answer: Prophylactic LMWH or DOAC (apixaban/rivaroxaban) during chemotherapy reduces VTE risk in high-risk cancers
Why
Consider prophylactic LMWH or apixaban/rivaroxaban for selected ambulatory patients on chemotherapy with Khorana≥2, after checking bleeding risk and drug interactions. Trials show substantial VTE reduction, balanced against bleeding. Mrs Payne already has PE and needs treatment-dose anticoagulation; this is primary prevention in a different patient.
Key point
Khorana≥2 + low bleeding risk: consider prophylaxis with oncology. Existing PE needs therapeutic treatment.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.